The company
Innovative Eyewear, Inc.
LUCY · Nasdaq
LUCY stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 14.8% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $2.9M
- Insider sales, 12 months
- $146K
- Officials’ trades on record
- 0
- Institutions holding
- 11 (+4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| David Eric CohenChief Technology Officer | sold | 6,136at $0.6802 | 19 Aug 2026filed 24 Aug 2026 |
| Harrison R. GrossChief Executive Officer | sold | 8,252at $0.6916 | 19 Aug 2026filed 24 Aug 2026 |
| Harrison R. GrossChief Executive Officer | sold | 5,722at $0.705 | 19 Aug 2026filed 24 Aug 2026 |
| Joaquin AbondanoChief Operating Officer | sold | 5,020at $0.6765 | 19 Aug 2026filed 24 Aug 2026 |
| Konrad DabrowskiChief AI & Growth Officer | sold | 6,935at $0.6911 | 19 Aug 2026filed 24 Aug 2026 |
| Oswald GayleChief Financial Officer | sold | 7,959at $0.6745 | 19 Aug 2026filed 24 Aug 2026 |
| David Eric CohenChief Technology Officer | sold | 1,860at $1.17 | 6 Jul 2026filed 24 Aug 2026 |
| David Eric CohenChief Technology Officer | sold | 1,860at $1.11 | 9 Apr 2026filed 24 Aug 2026 |
| David Eric CohenChief Technology Officer | sold | 5,913at $1.04 | 2 Apr 2026filed 24 Aug 2026 |
| Harrison R. GrossChief Executive Officer | sold | 13,764at $1.07 | 2 Apr 2026filed 24 Aug 2026 |
| Joaquin AbondanoChief Operating Officer | sold | 4,779at $1.05 | 2 Apr 2026filed 24 Aug 2026 |
| Konrad DabrowskiChief AI & Growth Officer | sold | 6,692at $1.06 | 2 Apr 2026filed 24 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Cetera Investment Advisersadded · filed 12 Aug 2026 | 577,350$450K | +77,350+15.5% |
| XTX Topco Ltdnew · filed 14 Aug 2026 | 40,996$32K | +40,996 |
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 29,596$23K | +29,596 |
| KEYBANK NATIONAL ASSOCIATIONadded · filed 28 Jul 2026 | 20,000$16K | +5,000+33.3% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 18,135$14K | -42,382−70.0% |
| JANE STREET GROUP, LLCnew · filed 14 Aug 2026 | 12,130$9,461 | +12,130 |
| UBS Group AGnew · filed 13 Aug 2026 | 5,186$4,045 | +5,186 |
| Tower Research Capital LLC (TRC)added · filed 11 Aug 2026 | 3,469$2,706 | +1,710+97.2% |
| JONES FINANCIAL COMPANIES LLLPunchanged · filed 14 Aug 2026 | 614$481 | 00.0% |
| WELLS FARGO & COMPANYunchanged · filed 14 Aug 2026 | 300$234 | 00.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.